Skip to main content
Clinical Trials/NL-OMON33126
NL-OMON33126
Not yet recruiting
Not Applicable

the Application of an Electronic Nose in the Early detection of ASpergillosis - the AENEAS study

Academisch Medisch Centrum0 sites80 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
fungal pneumonia
Sponsor
Academisch Medisch Centrum
Enrollment
80
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients that
  • 1\. are 18 years of age or older
  • 2\. will undergo treatment for a hematological malignancy expected to result in grade 4 neutropenia (according to CTCAE 3\.0, i.e. \<0\.5 x 109 neutrophils/L) of prolonged duration (i.e., more than 7 days), e.g. hematopoietic stem cell transplantation or induction/consolidation treatment for acute myeloid leukaemia
  • 3\. have given written informed consent

Exclusion Criteria

  • 1\. a previously diagnosed invasive mycosis, or
  • 2\. the inability to perform the breathing manoeuvre needed for eNose\-analysis of exhaled air

Outcomes

Primary Outcomes

Not specified

Similar Trials